Xcell Biosciences Company

Building products that enable propagation and gene editing in challenging cell types for clinical research and cell therapy applications.
Xcell Biosciences, Inc., is developing revolutionary products and workflows that empower scientists in important fields including cancer research, immunology, stem cell biology, and cell therapy development. Xcell’s first product, the Avatar™ system, offers a powerful new tool allowing for complete control of key physiological conditions found in cellular microenvironments. The Avatar system empowers researchers and drug developers with new capabilities, including propagation of difficult samples such as tumor biopsies and other primary cell types. The technology also offers dramatic improvements in transfection and gene editing efficiencies in primary cell populations for regenerative medicine and cell-based therapy applications. For more information, visit www.xcellbio.com.
Technology: mHealth
Industry: P4 Medicine
Headquarters: United States
Founded Date: 2012
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 4
Total Funding: $12.1M
Estimated Revenue: Less than $1M
Last Funding Type: Series A

Visit Website
innovate@xcellbio.com
https://twitter.com/XcellBio
Register and Claim Ownership